Skip to main content

Table 7 Cost-utility analysis–robustness test

From: Long-term cost-utility analysis of remote monitoring of older patients with pacemakers: the PONIENTE study

Variables All Conventional Monitoring (CM) group Remote Monitoring (RM) group Difference per patient
(n = 10,000) (n = 5000) (n = 5000)
n Mean SD n Mean SD n Mean SD Mean dif. p-value
EQ5 DM12 10,000 0.87 0.82 5000 0.81 0.73 5000 0.93 0.90 −0.12 < 0.001
EQ5 DM60 10,000 0.72 0.61 5000 0.74 0.66 5000 0.69 0.55 0.06 < 0.001
QALYM60 10,000 3.43 2.34 5000 3.48 2.48 5000 3.38 2.19 0.10 0.022
Cost/QalyM60 (€) 10,000 215.58 543.95 5000 238.73 721.12 5000 192.43 265.94 46.30 < 0.001
Cost/patient (€) 10,000    5000 438.60 324.29 5000 384.92 187.35 53.68 < 0.001
ICER 501.48